GeneDx Holdings Corp.
WGS
$98.01
$0.740.76%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 302.16M | 263.18M | 237.71M | 214.91M | 195.65M |
| Total Other Revenue | 3.29M | 4.05M | 5.95M | 6.94M | 6.91M |
| Total Revenue | 305.45M | 267.23M | 243.66M | 221.85M | 202.57M |
| Cost of Revenue | 111.00M | 108.23M | 108.20M | 110.57M | 113.44M |
| Gross Profit | 194.45M | 159.00M | 135.46M | 111.28M | 89.13M |
| SG&A Expenses | 166.93M | 162.42M | 162.12M | 172.88M | 191.49M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 3.41M | 3.31M | 4.32M | 4.16M | 4.93M |
| Total Operating Expenses | 326.91M | 317.17M | 320.45M | 339.68M | 364.95M |
| Operating Income | -21.46M | -49.94M | -76.80M | -117.83M | -162.39M |
| Income Before Tax | -52.63M | -84.23M | -118.33M | -135.88M | -176.69M |
| Income Tax Expenses | -343.00K | -730.00K | -855.00K | -861.00K | -926.00K |
| Earnings from Continuing Operations | -52.29 | -83.50 | -117.47 | -135.02 | -175.77 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -52.29M | -83.50M | -117.47M | -135.02M | -175.77M |
| EBIT | -21.46M | -49.94M | -76.80M | -117.83M | -162.39M |
| EBITDA | -408.00K | -23.65M | -47.77M | -83.68M | -124.85M |
| EPS Basic | -1.98 | -3.17 | -4.51 | -5.25 | -7.51 |
| Normalized Basic EPS | -0.92 | -1.76 | -2.37 | -2.92 | -4.38 |
| EPS Diluted | -1.98 | -3.17 | -4.51 | -5.25 | -7.51 |
| Normalized Diluted EPS | -0.92 | -1.76 | -2.37 | -2.92 | -4.38 |
| Average Basic Shares Outstanding | 107.56M | 105.69M | 104.38M | 103.19M | 97.19M |
| Average Diluted Shares Outstanding | 107.56M | 105.69M | 104.38M | 103.19M | 97.19M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
